Physician profile
Foad Farhoumand
NPI 1013051937
$1,564.31
in general payments reported to CMS, 2019-2025
9 companies · $870 in 2025
The $870 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.69 · 2021: $12.26 · 2023: $55.29 · 2024: $607 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857 · Gift: $575 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.36 |
| Gift | $575.00 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $575.00 | 2025 | |
| Zimvie INC. | $446.86 | 2024-2025 | |
| Align Technology, INC. | $128.14 | 2023-2025 | Invisalign |
| Vertex Pharmaceuticals Incorporated | $124.94 | 2025 | |
| Envista Holdings Corporation | $101.91 | 2024 | I-Cat Flx/Flx Mv |
| Straumann USA LLC | $100.00 | 2024 | |
| Dentsply Sirona INC | $45.42 | 2020-2024 | Protaper Gold Conform Fit |
| Orapharma, A Division of Bausch Health US, LLC | $27.49 | 2021-2023 | Arestin |
| Philips North America LLC | $14.55 | 2025 | Whitening Pens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Foad Farhoumand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.